Literature DB >> 6337213

Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.

M A Charles, M Suzuki, N Waldeck, L E Dodson, L Slater, K Ong, A Kershnar, B Buckingham, M Golden.   

Abstract

Because immune mechanisms are associated with insulin-dependent diabetes, multiple organ specific and xenogeneic cytotoxicity assays were developed. Human cellular and antibody effector systems were incubated with 51Cr-labeled dispersed normal rat islet target cells. In eight of 11 diabetic patients, nonenriched mononuclear cells incubated with islet target cells were more cytotoxic than cells from age- and sex-matched controls (p less than 0.01). When non-T cell-enriched mononuclear cells were used at diabetes onset, seven of 11 patients' cells showed excessive islet cytotoxicity (p less than 0.05). In four patients showing elevated cytotoxicity at diabetes onset, cytotoxicity decreased to control levels during diabetes remission. Islet specificity was suggested in that mononuclear cells derived from diabetic subjects did not mediate cytotoxicity against rat spleen or macrophage target cells. Three cytotoxic antibody mechanisms were also evaluated. C-dependent antibody-mediated cytotoxicity with the use of patient serum-coated islet target cells was elevated above control levels in four of 14 patients. Antibody-dependent cellular cytotoxicity exceeded control values in only two of 16 patients, although four assay systems were evaluated. C-augmented antibody-dependent cellular cytotoxicity was elevated in three of 14 patients. No differences were observed for antibody-mediated mechanisms in four patients evaluated at both diabetes onset and remission. Cytotoxic antibody was present in only about one-half of the patients showing increased cellular cytotoxicity, whereas most patients expressing increased cytotoxic antibody had cellular cytotoxicity. Islet cell cytotoxicity assays with the use of effector systems from patients with recent onset insulin-dependent diabetes suggest that direct cellular cytotoxicity is more active than antibody-mediated cytotoxic mechanisms, and that cellular cytotoxicity can correlate with disease activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337213

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

2.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.

Authors:  M A Charles; M Suzuki; L Slater; N Waldeck; K Ong
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

5.  Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity.

Authors:  T Maruyama; I Takei; M Taniyama; K Kataoka; S Matsuki
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

6.  Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.

Authors:  K Negishi; N Waldeck; G Chandy; B Buckingham; A Kershnar; L Fisher; S Gupta; M A Charles
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

7.  Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.

Authors:  P MacKay; J Jacobson; A Rabinovitch
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  Identification of cells responsible for the suppression of anti-beta-cell cytotoxicity in type I (insulin-dependent) diabetes mellitus.

Authors:  J Krug; B Bierwolf; E Lampeter; H J Verlohren; D Lohmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

9.  Major histocompatibility complex protein expression on pancreas and pancreatic islet endocrine cell subsets.

Authors:  I Lautenschlager; K Inkinen; E Taskinen; M A Charles; P Hayry
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

10.  Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.

Authors:  B Marner; T Agner; C Binder; A Lernmark; J Nerup; T Mandrup-Poulsen; S Walldorff
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.